Teva reaches agreement with florida to settle the state's opioid-related claims

Tel aviv, israel & parsippany, n.j.--(business wire)--teva pharmaceuticals, a u.s. affiliate of teva pharmaceutical industries ltd. (nyse and tase: teva) and its affiliates, has reached an agreement with the attorney general of florida that settles the state's and its subdivisions opioid-related claims. the settlement will provide florida $177 million over 15 years, as well as life-saving medicine generic narcan® (naloxone hydrochloride nasal spray), valued at $84 million (wholesale acquisition
TEVA Ratings Summary
TEVA Quant Ranking